3 ms·
What's the advantage of stopping reporting of adverse events? Doesn't that just make it easier for dangerous / ineffective (but fantastically expensive) drugs t
by DanBC 11y ago
What's the advantage of stopping reporting of adverse events? Doesn't that just make it easier for dangerous / ineffective (but fantastically expensive) drugs to come to market?
- Thriptic 11y agoIn very sick patients (those generally filing for compassionate use) it's sometimes difficult to pin down whether the drug actually caused a problem or death. Were the patients properly adherent? Did they have comorbidities? Were they simply too sick and died? A few deaths might cause the FDA to order additional trials which may actually not be necessary, to the tune of millions of dollars. If you were a company that spent years and hundreds of millions trying to bring a product to market, would you want to take that risk?
- Thriptic 11y agoIn addition (adding on to my comment below), companies don't want the FDA to try to use the outcomes of patients taking the drug for compassionate use as a metric of efficacy before a proper phase 2 or 3 clinical trial has been run, for the exact same reasons.